Blue Press Journal – As President Donald Trump’s deadline for large drugmakers to make “binding commitments” to cut prices expired on Monday, a new report from Senator Bernie Sanders has revealed that the cost of hundreds of prescriptions has risen in the United States since Trump took office in January. The report, titled “The Art of the Bad Deal: Trump’s Failure to Lower Prescription Drug Prices,” was released by Sanders, the ranking member of the Senate Health, Education, Labor, and Pensions Committee.
According to the report, committee staffers documented price increases for 688 medications, including 310 brand-name drugs and 378 generic ones, during Trump’s second term. The median increase was 5.5%, with 25 treatments more than doubling in cost. The report also notes that 15 of the 17 companies that received a letter from President Trump on July 31, 2025, raised the price of at least one product since Trump took office. Furthermore, since Trump sent letters asking drug companies to lower prices, the prices of 87 drugs have increased.
The report’s findings come as Trump announced that he will impose a 100% tariff on pharmaceutical products starting October 1, unless a product’s manufacturer is making or planning to make the product in the US. Insurers are already reporting that higher drug prices arising from tariffs will result in higher health insurance premiums.
Sanders, a longtime advocate of Medicare for All, called on Trump to support his legislation ensuring Americans pay no more than others for the same prescription drug. “If President Trump is serious about making real change, he will support my legislation,” Sanders said. “Now is the time to end the greed of the pharmaceutical industry.”
The report’s release highlights the ongoing issue of rising prescription drug prices in the US and the urgent need for reform. As the debate continues, Sanders’ report underscores the importance of holding pharmaceutical companies accountable for their pricing practices.
Blue Press Journal 